{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:25:01Z","timestamp":1790727901792,"version":"4.1.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"\n Background<\/jats:title>\n \n This study investigated the association between metabolic-inflammatory markers and\n Helicobacter pylori<\/jats:italic>\n (HP) infection using interpretable machine learning models, with a focus on the triglyceride-glucose (TyG) index, TyG\/HDL-C ratio, and systemic inflammatory biomarkers.\n <\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Data from 2,924 NHANES participants and 1,021 patients from the Second Hospital of Jilin University were analyzed. Associations between metabolic-inflammatory markers and HP were assessed using multivariable regression. Eleven machine learning models were compared for predictive performance, evaluated by AUC, accuracy, sensitivity, specificity, precision, F1 score, and Kappa statistic. Interpretability was assessed via SHAP values, calibration plots, confusion matrices, and decision curve analysis.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n In NHANES, the TyG index was independently associated with HP infection (OR = 1.25, 95% CI 1.06\u20131.48,\n P<\/jats:italic>\n = 0.009), and the TyG\/HDL-C ratio remained significant after full adjustment (OR = 1.16, 95% CI 1.07\u20131.25,\n P<\/jats:italic>\n &lt; 0.001), while SIRI, IBI, and CRP lost significance. In the external Chinese cohort, the TyG association attenuated (\n P<\/jats:italic>\n = 0.057), but higher TyG\/HDL-C quartiles remained significant. Among 11 algorithms, Random Forest (RF) and Gaussian Process (GP) achieved the highest AUCs on the training set (both 0.97) but dropped markedly on the validation set (both 0.75), indicating overfitting. In contrast, XGBoost (XGB) and MLP maintained more consistent AUCs between training (0.77) and validation (0.77), reflecting better generalization. DeLong\u2019s test indicated that both RF and XGB significantly outperformed baseline models (\n P<\/jats:italic>\n &lt; 0.001), while XGB demonstrated more stable validation performance. Decision curve and SHAP analyses supported the clinical relevance of XGB, highlighting Race and Age as dominant contributors.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n The TyG index and TyG\/HDL-C ratio were independently associated with HP infection. Among machine learning models, XGBoost demonstrated the most stable and generalizable performance (AUC 0.77 in both training and validation), whereas RF and GP (AUC 0.97 \u2192 0.75) exhibited overfitting. These results suggest that XGB provides a more reliable framework for infection risk prediction, though the cross-sectional design precludes causal inference.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fnut.2025.1674585","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:25:14Z","timestamp":1763562314000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Associations between metabolic-inflammatory biomarkers and Helicobacter pylori infection: an interpretable machine learning prediction approach"],"prefix":"10.3389","volume":"12","author":[{"given":"Yue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifeng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2337\/dc08-1195","article-title":"Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study.","volume":"32","author":"Faerch","year":"2009","journal-title":"Diabetes Care"},{"key":"B2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/joim.13687","article-title":"Insulin resistance probability score and incident cardiovascular disease.","volume":"294","author":"Louie","year":"2023","journal-title":"J Intern Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"101566","DOI":"10.1016\/j.diabet.2024.101566","article-title":"Insulin-based or non-insulin-based insulin resistance indicators and risk of long-term cardiovascular and all-cause mortality in the general population: a 25-year cohort study.","volume":"50","author":"Lin","year":"2024","journal-title":"Diabetes Metab"},{"key":"B4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1152\/physiol.00012.2007","article-title":"Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension.","volume":"22","author":"Jonk","year":"2007","journal-title":"Physiology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41588-023-01625-2","article-title":"Comprehensive genetic study of the insulin resistance marker TG:hdl-c in the UK Biobank.","volume":"56","author":"Oliveri","year":"2024","journal-title":"Nat Genet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12933-022-01523-7","article-title":"Triglyceride glucose index for the detection of the severity of coronary artery disease in different glucose metabolic states in patients with coronary heart disease: a RCSCD-TCM study in China.","volume":"21","author":"Su","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/5584_2019_357","article-title":"Epidemiology, diagnosis and risk factors of Helicobacter pylori infection.","volume":"1149","author":"Kotilea","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.3748\/wjg.v24.i29.3204","article-title":"Helicobacter pylori and extragastric diseases: a review.","volume":"24","author":"Gravina","year":"2018","journal-title":"World J Gastroenterol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2217\/fca-2016-0008","article-title":"Hp: an inflammatory indicator in cardiovascular disease.","volume":"12","author":"Graves","year":"2016","journal-title":"Future Cardiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"794445","DOI":"10.3389\/fcvm.2022.794445","article-title":"An updated meta-analysis of the relationship between Helicobacter pylori infection and the risk of coronary heart disease.","volume":"9","author":"Tong","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.3748\/wjg.15.2701","article-title":"Helicobacter pylori infection and endocrine disorders: Is there a link?","volume":"15","author":"Papamichael","year":"2009","journal-title":"World J Gastroenterol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"340765","DOI":"10.1155\/2014\/340765","article-title":"The Relationship between H. pylori infection and osteoporosis in Japan.","volume":"2014","author":"Asaoka","year":"2014","journal-title":"Gastroenterol Res Pract"},{"key":"B13","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1128\/CMR.00011-10","article-title":"Helicobacter pylori and gastric cancer: factors that modulate disease risk.","volume":"23","author":"Wroblewski","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13098-024-01422-9","article-title":"Association of triglyceride-glucose index with helicobacter pylori infection and mortality among the US population.","volume":"16","author":"Zhu","year":"2024","journal-title":"Diabetol Metab Syndr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","article-title":"The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: Nhanes 2003-2018.","volume":"23","author":"Dang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12933-024-02571-x","article-title":"Inflammatory markers link triglyceride-glucose index and obesity indicators with adverse cardiovascular events in patients with hypertension: insights from three cohorts.","volume":"24","author":"Huang","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1038\/s41598-025-88156-4","article-title":"Machine Learning-Based predictive model for adolescent metabolic syndrome: utilizing data from NHANES 2007-2016.","volume":"15","author":"Zhang","year":"2007","journal-title":"Sci Rep"},{"key":"B18","first-page":"4765","article-title":"A unified approach to interpreting model predictions.","volume-title":"Proceedings of the Advances in Neural Information Processing Systems (NIPS).","author":"Lundberg","year":"2017"},{"key":"B19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1590\/S0004-2803.230302023-44","article-title":"Association between nonalcoholic fatty pancreatic disease and triglyceride\/glucose index.","volume":"60","author":"Andrade","year":"2023","journal-title":"Arq Gastroenterol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"475","DOI":"10.47162\/RJME.62.2.13","article-title":"Triglyceride and glucose index: a useful tool for non-alcoholic liver disease assessed by liver biopsy in patients with metabolic syndrome?","volume":"62","author":"Amzolini","year":"2021","journal-title":"Rom J Morphol Embryol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12933-023-02030-z","article-title":"The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001-2018.","volume":"22","author":"Zhang","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.numecd.2021.11.017","article-title":"Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome.","volume":"32","author":"Son","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1186\/s12933-024-02536-0","article-title":"Relationships among Helicobacter pylori seropositivity, the triglyceride-glucose index, and cardiovascular disease: a cohort study using the NHANES database.","volume":"23","author":"Tang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1365-3083.1993.tb01666.x","article-title":"Gastric interleukin-8 and IgA IL-8 autoantibodies in Helicobacter pylori infection.","volume":"37","author":"Crabtree","year":"1993","journal-title":"Scand J Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/s1590-8658(01)80711-8","article-title":"Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty.","volume":"33","author":"Kowalski","year":"2001","journal-title":"Dig Liver Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1046\/j.1523-5378.1998.08018.x","article-title":"Effect of H. pylori infection and CagA status on leukocyte counts and liver function tests: extra-gastric manifestations of H. pylori infection.","volume":"3","author":"Graham","year":"1998","journal-title":"Helicobacter"},{"key":"B27","doi-asserted-by":"publisher","first-page":"100890","DOI":"10.1016\/j.lana.2024.100890","article-title":"Helicobacter pylori infection in the United States beyond NHANES: a scoping review of seroprevalence estimates by racial and ethnic groups.","volume":"41","author":"McMahon","year":"2024","journal-title":"Lancet Reg Health Am"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.1038\/s41598-025-88345-1","article-title":"Assessing the diagnostic accuracy of machine learning algorithms for identification of asthma in United States adults based on NHANES dataset.","volume":"15","author":"Kohandel Gargari","year":"2025","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1587540","DOI":"10.3389\/fmed.2025.1587540","article-title":"Machine learning for prediction of Helicobacter pylori infection based on basic health examination data in adults: a retrospective study.","volume":"12","author":"Wang","year":"2025","journal-title":"Front Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1186\/s12916-025-04379-2","article-title":"Artificial intelligence-assisted endoscopic diagnosis system for diagnosing Helicobacter pylori infection: a multicenter study.","volume":"23","author":"Hu","year":"2025","journal-title":"BMC Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e70078","DOI":"10.1111\/hel.70078","article-title":"Real-Time Prediction of Helicobacter pylori infection using a deep learning model during esophagogastroduodenoscopy: a prospective multicenter study.","volume":"30","author":"Yan-Dong","year":"2025","journal-title":"Helicobacter"},{"key":"B32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.5009\/gnl250159","article-title":"Influence of Helicobacter pylori infection and eradication therapy on nutrition and metabolic parameters.","volume":"19","author":"Sugimoto","year":"2025","journal-title":"Gut Liver"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1674585\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:25:15Z","timestamp":1763562315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1674585\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":32,"alternative-id":["10.3389\/fnut.2025.1674585"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2025.1674585","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"article-number":"1674585"}}